Pramlintide: A human amylin analog reduced postprandial plasma glucose, insulin and c-peptide concentrations in patients with type II diabetes. - Thompson,R.G.; Gottlieb,A.; Organ,K.; Koda,J.; Kisicki,J.; Kolterman,O.G. (Diabet Med, 1997)